
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9771203
[patent_doc_number] => 20140294867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING'
[patent_app_type] => utility
[patent_app_number] => 14/203479
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 28881
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14203479
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/203479 | Site-specific antibody-drug conjugation through glycoengineering | Mar 9, 2014 | Issued |
Array
(
[id] => 9720933
[patent_doc_number] => 20140256635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'ANTI-ANGIOGENIC MOLECULES, NANOSTRUCTURES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/202682
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7195
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14202682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/202682 | Anti-angiogenic molecules, nanostructures and uses thereof | Mar 9, 2014 | Issued |
Array
(
[id] => 10514946
[patent_doc_number] => 09241977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Enhanced anabolic cytokine production and delivery system'
[patent_app_type] => utility
[patent_app_number] => 14/188899
[patent_app_country] => US
[patent_app_date] => 2014-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 3859
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/188899 | Enhanced anabolic cytokine production and delivery system | Feb 24, 2014 | Issued |
Array
(
[id] => 10954816
[patent_doc_number] => 20140357839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'VANCOMYCIN B HYDROCHLORIDE CRYSTALLINE FORM 1'
[patent_app_type] => utility
[patent_app_number] => 14/187594
[patent_app_country] => US
[patent_app_date] => 2014-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2586
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187594 | VANCOMYCIN B HYDROCHLORIDE CRYSTALLINE FORM 1 | Feb 23, 2014 | Abandoned |
Array
(
[id] => 9685359
[patent_doc_number] => 20140242123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'SACCHARIDE-PEPTIDE HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 14/186973
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15215
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186973 | Saccharide-peptide hydrogels | Feb 20, 2014 | Issued |
Array
(
[id] => 9922863
[patent_doc_number] => 08980824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Tubulysin compounds, methods of making and use'
[patent_app_type] => utility
[patent_app_number] => 14/177376
[patent_app_country] => US
[patent_app_date] => 2014-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 28607
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14177376
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/177376 | Tubulysin compounds, methods of making and use | Feb 10, 2014 | Issued |
Array
(
[id] => 10695035
[patent_doc_number] => 20160041181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'NMR ASSAY TO SCREEN PROTEIN-PROTEIN INTERACTION INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/765626
[patent_app_country] => US
[patent_app_date] => 2014-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9428
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/765626 | NMR ASSAY TO SCREEN PROTEIN-PROTEIN INTERACTION INHIBITORS | Feb 3, 2014 | Abandoned |
Array
(
[id] => 9569780
[patent_doc_number] => 20140187494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1'
[patent_app_type] => utility
[patent_app_number] => 14/138521
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 25635
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138521
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138521 | Inhibition of inflammation using antagonists of MUC1 | Dec 22, 2013 | Issued |
Array
(
[id] => 10467205
[patent_doc_number] => 20150352219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'CONJUGATE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/649902
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649902
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649902 | Conjugate compounds | Dec 5, 2013 | Issued |
Array
(
[id] => 10467205
[patent_doc_number] => 20150352219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'CONJUGATE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/649902
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649902
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649902 | Conjugate compounds | Dec 5, 2013 | Issued |
Array
(
[id] => 10389780
[patent_doc_number] => 20150274788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'LANTIBIOTIC DERIVATIVES AND PROCESS FOR THEIR PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/648696
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15186
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648696
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648696 | Lantibiotic derivatives and process for their preparation | Nov 26, 2013 | Issued |
Array
(
[id] => 11827652
[patent_doc_number] => 09724380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Method and compositions for synchronizing time of insemination in gilts'
[patent_app_type] => utility
[patent_app_number] => 14/648182
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34172
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648182
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648182 | Method and compositions for synchronizing time of insemination in gilts | Nov 26, 2013 | Issued |
Array
(
[id] => 9510950
[patent_doc_number] => 20140147441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE'
[patent_app_type] => utility
[patent_app_number] => 14/084132
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17998
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084132
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084132 | COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE | Nov 18, 2013 | Abandoned |
Array
(
[id] => 13093331
[patent_doc_number] => 10065996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Streptavidin muteins and methods of using them
[patent_app_type] => utility
[patent_app_number] => 14/442376
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 7
[patent_no_of_words] => 20604
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442376
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442376 | Streptavidin muteins and methods of using them | Nov 17, 2013 | Issued |
Array
(
[id] => 9971162
[patent_doc_number] => 09018171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum '
[patent_app_type] => utility
[patent_app_number] => 14/080400
[patent_app_country] => US
[patent_app_date] => 2013-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 16
[patent_no_of_words] => 9469
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/080400 | Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum | Nov 13, 2013 | Issued |
Array
(
[id] => 10056224
[patent_doc_number] => 09095564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes'
[patent_app_type] => utility
[patent_app_number] => 14/071193
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4094
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/071193 | von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes | Nov 3, 2013 | Issued |
Array
(
[id] => 9463894
[patent_doc_number] => 20140128321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHOD AND USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES'
[patent_app_type] => utility
[patent_app_number] => 14/070212
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6336
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/070212 | METHOD AND USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES | Oct 31, 2013 | Abandoned |
Array
(
[id] => 10096954
[patent_doc_number] => 09133255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Products and methods using soy peptides to lower total and LDL cholesterol levels'
[patent_app_type] => utility
[patent_app_number] => 14/069013
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21010
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069013 | Products and methods using soy peptides to lower total and LDL cholesterol levels | Oct 30, 2013 | Issued |
Array
(
[id] => 10134951
[patent_doc_number] => 09168258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-27
[patent_title] => 'Methods and compositions for sleep disorders and other disorders'
[patent_app_type] => utility
[patent_app_number] => 14/066987
[patent_app_country] => US
[patent_app_date] => 2013-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12442
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14066987
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/066987 | Methods and compositions for sleep disorders and other disorders | Oct 29, 2013 | Issued |
Array
(
[id] => 9422382
[patent_doc_number] => 20140107033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 14/063792
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 26092
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/063792 | Methods for prevention and treatment of acute renal injury | Oct 24, 2013 | Issued |